BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Adeline Bertola. Rodent models of fatty liver diseasesLiver Research 2018; 2(1): 3 doi: 10.1016/j.livres.2018.03.001
2
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 369 doi: 10.1007/978-3-030-11748-1_14
3
Peter Lykke Eriksen, Hendrik Vilstrup, Kristoffer Rigbolt, Malte P. Suppli, Michael Sørensen, Sara Heebøll, Sanne S. Veidal, Fillip K. Knop, Karen Louise Thomsen. Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversionLiver International 2019; 39(11): 2094 doi: 10.1111/liv.14205
4
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceWorld Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
5
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
6
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza Potes. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(12): 2871 doi: 10.3390/nu11122871
7
Catherine M. Sampson, Andrea L. Dimet, Harshini Neelakantan, Kehinde O. Ogunseye, Heather L. Stevenson, Jonathan D. Hommel, Stanley J. Watowich. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese miceScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85051-6
8
Michelle L. Boland, Rhianna C. Laker, Karly Mather, Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland, Hilary Lewis, James Conway, Jacqueline Naylor, Silvia Guionaud, Michael Feigh, Sanne S. Veidal, Louise Lantier, Owen P. McGuinness, Joseph Grimsby, Cristina M. Rondinone, Lutz Jermutus, Martin R. Larsen, James L. Trevaskis, Christopher J. Rhodes. Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesisNature Metabolism 2020; 2(5): 413 doi: 10.1038/s42255-020-0209-6
9
Bader Zarrouki, Jeremie Boucher. Kupffer CellsMethods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
10
Waranya Chatuphonprasert, Yollada Sriset, Kanokwan Jarukamjorn. Continuous Consumption of Reused Palm Oil Induced Hepatic Injury, Depletion of Glutathione Stores, and Modulation of Cytochrome P450 Profiles in MicePolish Journal of Food and Nutrition Sciences 2019; 69(1): 53 doi: 10.31883/pjfns-2019-0009
11
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patientsBiology Open 2019; 8(5) doi: 10.1242/bio.041251
12
David H Ipsen, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?Advances in Nutrition 2020; 11(6): 1696 doi: 10.1093/advances/nmaa081
13
Hannah Zhang, Mélissa Léveillé, Emilie Courty, Aysim Gunes, Bich N. Nguyen, Jennifer L. Estall. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2020; 319(5): E863 doi: 10.1152/ajpendo.00321.2020
14
Diego Almanza, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, Jose A. Rodriguez-Nieves, Cory Colaneri, Todd Riley, Jill A. Macoska. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular SignatureDigestive Diseases and Sciences 2019; 64(5): 1257 doi: 10.1007/s10620-018-5398-4
15
João Pedroso, João Camporez, Luciana Belpiede, Rafaela Pinto, José Cipolla-Neto, Jose Donato. Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic ResonanceDiagnostics 2019; 9(4): 198 doi: 10.3390/diagnostics9040198
16
Jamie Bates, Archana Vijayakumar, Sarani Ghoshal, Bruno Marchand, Saili Yi, Dmytro Kornyeyev, Anna Zagorska, David Hollenback, Katie Walker, Kathy Liu, Swetha Pendem, David Newstrom, Robert Brockett, Igor Mikaelian, Saritha Kusam, Ricardo Ramirez, David Lopez, Li Li, Bryan C. Fuchs, David G. Breckenridge. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activationJournal of Hepatology 2020; 73(4): 896 doi: 10.1016/j.jhep.2020.04.037
17
Chisa Tometsuka, Noriko Funato, Kazunori Mizuno, Yuki Taga. Long-term intake of ginger protease-degraded collagen hydrolysate reduces blood lipid levels and adipocyte size in miceCurrent Research in Food Science 2021; 4: 175 doi: 10.1016/j.crfs.2021.03.003
18
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
19
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
20
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s GuideNutrients 2017; 9(10): 1072 doi: 10.3390/nu9101072
21
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in miceBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
22
Adeline Bertola. WITHDRAWN: Rodent models of fatty liver diseasesLiver Research 2018;  doi: 10.1016/j.livres.2018.02.005
23
Daniel Veyel, Kathrin Wenger, Andre Broermann, Tom Bretschneider, Andreas H. Luippold, Bartlomiej Krawczyk, Wolfgang Rist, Eric Simon. Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58030-6
24
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
25
Kirstine S Tølbøl, Maria NB Kristiansen, Henrik H Hansen, Sanne S Veidal, Kristoffer TG Rigbolt, Matthew P Gillum, Jacob Jelsing, Niels Vrang, Michael Feigh. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitisWorld Journal of Gastroenterology 2018; 24(2): 179-194 doi: 10.3748/wjg.v24.i2.179
26
Oren Tirosh. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease ProgressionOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/2548154
27
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructoseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
28
Aimo Kannt, Paulus Wohlfart, Andreas Nygaard Madsen, Sanne Skovgård Veidal, Michael Feigh, Dieter Schmoll. Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosisBritish Journal of Pharmacology 2021;  doi: 10.1111/bph.15427
29
Kikumi Ono-Moore, Matthew Ferguson, Michael Blackburn, Hassan Issafras, Sean Adams. Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in MiceNutrients 2016; 9(1): 16 doi: 10.3390/nu9010016
30
Geurt Stokman, Anita M. Hoek, Ditte Denker Thorbekk, Elsbet J. Pieterman, Sanne Skovgård Veidal, Brittany Basta, Marta Iruarrizaga‐Lejarreta, José W. Hoorn, Lars Verschuren, Jimmy F. P. Berbée, Patrick C. N. Rensen, Tore Skjæret, Cristina Alonso, Michael Feigh, John J. P. Kastelein, Scott L. Friedman, Hans M. G. Princen, David A. Fraser. Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivativeLiver International 2020; 40(11): 2860 doi: 10.1111/liv.14643
31
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster. Alternative RNA Splicing in Fatty Liver DiseaseFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.613213
32
Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara, Maria Ybanez, Brittany Allen, Sebastiao Martins, M. Isabel Fiel, Nicolas Goossens, Hsin-I. Chou, Yujin Hoshida, Scott L. Friedman. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancerJournal of Hepatology 2018; 69(2): 385 doi: 10.1016/j.jhep.2018.03.011
33
Priyankar Dey. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease modelsLife Sciences 2020; 258: 118172 doi: 10.1016/j.lfs.2020.118172
34
Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang, Keld Fosgerau. Mouse models of nonalcoholic steatohepatitis in preclinical drug developmentDrug Discovery Today 2017; 22(11): 1707 doi: 10.1016/j.drudis.2017.06.007
35
Jonathan D Roth, Michael Feigh, Sanne S Veidal, Louise KD Fensholdt, Kristoffer T Rigbolt, Henrik H Hansen, Li C Chen, Mathieu Petitjean, Weslyn Friley, Niels Vrang, Jacob Jelsing, Mark Young. INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisWorld Journal of Gastroenterology 2018; 24(2): 195-210 doi: 10.3748/wjg.v24.i2.195
36
Amandine Everard, Hubert Plovier, Marialetizia Rastelli, Matthias Van Hul, Alice de Wouters d’Oplinter, Lucie Geurts, Céline Druart, Sylvie Robine, Nathalie M. Delzenne, Giulio G. Muccioli, Willem M. de Vos, Serge Luquet, Nicolas Flamand, Vincenzo Di Marzo, Patrice D. Cani. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosisNature Communications 2019; 10(1) doi: 10.1038/s41467-018-08051-7
37
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitisDiabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
38
Kandy T Velázquez, Reilly T Enos, Jackie E Bader, Alexander T Sougiannis, Meredith S Carson, Ioulia Chatzistamou, James A Carson, Prakash S Nagarkatti, Mitzi Nagarkatti, E Angela Murphy. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in miceWorld Journal of Hepatology 2019; 11(8): 619-637 doi: 10.4254/wjh.v11.i8.619
39
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, Marc Foretz, Patrick C. Even, Dalila Azzout‐Marniche, Andreas Nygaard Madsen, Martin Illemann, Karen Mandrup, Michael Feigh, Jörg Czech, Heiner Glombik, Jacob A. Olsen, Wolfgang Hennerici, Klaus Steinmeyer, Ralf Elvert, Tamara R. Castañeda, Aimo Kannt. Activation of Adenosine Monophosphate—Activated Protein Kinase Reduces the Onset of Diet‐Induced Hepatocellular Carcinoma in MiceHepatology Communications 2020; 4(7): 1056 doi: 10.1002/hep4.1508
40
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Animal models of NAFLD from the pathologist's point of viewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 929 doi: 10.1016/j.bbadis.2018.04.024
41
Inga Bae-Gartz, Philipp Kasper, Nora Großmann, Saida Breuer, Ruth Janoschek, Tobias Kretschmer, Sarah Appel, Lisa Schmitz, Christina Vohlen, Alexander Quaas, Michal R. Schweiger, Christina Grimm, Axel Fischer, Nina Ferrari, Christine Graf, Christian K. Frese, Sonja Lang, Münevver Demir, Christoph Schramm, Gregor Fink, Tobias Goeser, Jörg Dötsch, Eva Hucklenbruch-Rother. Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programmingScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72022-6
42
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
43
Manuel Baader, Tom Bretschneider, Andre Broermann, Joerg F Rippmann, Birgit Stierstorfer, Christian A Kuttruff, Michael Mark. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosisBritish Journal of Pharmacology 2018; 175(4): 693 doi: 10.1111/bph.14118
44
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, Andreas Geier. Animal models of NAFLD from a hepatologist's point of viewBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 943 doi: 10.1016/j.bbadis.2018.06.023
45
Malte P. Suppli, Kristoffer T. G. Rigbolt, Sanne S. Veidal, Sara Heebøll, Peter Lykke Eriksen, Mia Demant, Jonatan I. Bagger, Jens Christian Nielsen, Denise Oró, Sebastian W. Thrane, Asger Lund, Charlotte Strandberg, Merete J. Kønig, Tina Vilsbøll, Niels Vrang, Karen L. Thomsen, Henning Grønbæk, Jacob Jelsing, Henrik H. Hansen, Filip K. Knop. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individualsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(4): G462 doi: 10.1152/ajpgi.00358.2018
46
Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas. A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in MiceHepatology Communications 2019; 3(9): 1221 doi: 10.1002/hep4.1405
47
Michelle L Boland, Stephanie Oldham, Brandon B Boland, Sarah Will, Jean-Martin Lapointe, Silvia Guionaud, Christopher J Rhodes, James L Trevaskis. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunctionWorld Journal of Gastroenterology 2018; 24(16): 1748-1765 doi: 10.3748/wjg.v24.i16.1748
48
S. Gómez-Zorita, I. Milton-Laskibar, M. T. Macarulla, L. Biasutto, A. Fernández-Quintela, J. Miranda, A. Lasa, N. Segues, L. Bujanda, M. P. Portillo. Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrolFood & Function 2021; 12(7): 3266 doi: 10.1039/D0FO03320K
49
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating PeptidesFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
50
Aimo Kannt, Efstathia Papada, Claire Kammermeier, Giuseppe D'Auria, Nuria Jiménez‐Hernández, Martin Stephan, Uwe Schwahn, Andreas Nygaard Madsen, Mette Viberg Østergaard, George Dedoussis, M. Pilar Francino. Mastiha ( Pistacia lentiscus ) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis Molecular Nutrition & Food Research 2019; 63(24): 1900927 doi: 10.1002/mnfr.201900927
51
Anurag Mishra, Tamara R. Castañeda, Erik Bader, Bettina Elshorst, Sheila Cummings, Petra Scherer, Dinesh S. Bangari, Claudia Loewe, Herman Schreuder, Christoph Pöverlein, Mike Helms, Seth Jones, Gernot Zech, Thomas Licher, Michael Wagner, Manfred Schudok, Meltsje Hoop, Alleyn T. Plowright, Jens Atzrodt, Aimo Kannt, Iina Laitinen, Volker Derdau. Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic SteatohepatitisAdvanced Science 2020; 7(24): 2002997 doi: 10.1002/advs.202002997
52
Victoria S. Jensen, Pernille Tveden-Nyborg, Christina Zacho-Rasmussen, Michelle L. Quaade, David H. Ipsen, Henning Hvid, Christian Fledelius, Erik M. Wulff, Jens Lykkesfeldt. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent modelsJournal of Pharmacological and Toxicological Methods 2020; 101: 106651 doi: 10.1016/j.vascn.2019.106651
53
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
54
Beatriz Carmona-Hidalgo, Isabel González-Mariscal, Adela García-Martín, María E. Prados, Francisco Ruiz-Pino, Giovanni Appendino, Manuel Tena-Sempere, Eduardo Muñoz. Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in micePhytomedicine 2021; 81: 153426 doi: 10.1016/j.phymed.2020.153426
55
Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros. The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic SteatohepatitisHepatology Communications 2020; 4(9): 1302 doi: 10.1002/hep4.1558
56
Dominika Stygar, Tomasz Sawczyn, Agnieszka Dulska, Elżbieta Chełmecka, Łukasz Mielańczyk, Natalia Matysiak, Michał Kukla, Maciej Idzik, Jan Augustyniak, Andrzej Gabriel, Konrad Karcz, Jerzy Jochem. Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) ratsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87293-w
57
F. Anthony Romero, Christopher T. Jones, Yingzi Xu, Martijn Fenaux, Randall L. Halcomb. The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver DiseaseJournal of Medicinal Chemistry 2020; 63(10): 5031 doi: 10.1021/acs.jmedchem.9b01701
58
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver StudiesJournal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14